Brain and Gene Expression Responses to Exercise in Chronic Back Pain
CLBPE
Frontostriatal Connectivity and Gene Expression in Exercise-induced Relief of Back Pain
1 other identifier
interventional
57
1 country
1
Brief Summary
This study is registered retrospectively for transparency. This mechanistic randomized controlled trial examined whether a 14-week supervised physical exercise training program reduces chronic low back pain (CLBP) by modulating frontostriatal brain connectivity and immune-related gene expression. Fifty-seven adults with CLBP were randomized to exercise training or wait-list control. Participants underwent pre- and post-intervention MRI, questionnaires, and blood sampling. The study tested whether reductions in nucleus accumbens-medial prefrontal cortex connectivity and changes in inflammatory gene expression mediated exercise-induced pain relief.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Mar 2017
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 31, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 14, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
December 14, 2021
CompletedFirst Submitted
Initial submission to the registry
March 14, 2026
CompletedFirst Posted
Study publicly available on registry
March 18, 2026
CompletedMarch 18, 2026
March 1, 2026
4.7 years
March 14, 2026
March 14, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Chronic Low Back Pain Intensity
Self-reported average low back pain intensity measured using an 11-point Numerical Rating Scale (NRS; 0-10), where 0 = "no pain" and 10 = "worst imaginable pain."
Assessed at Baseline (Pre-intervention, Week 0) and Post-intervention (Week 14)
Secondary Outcomes (6)
Oswestry Low Back Pain Disability Index (ODI)
Assessed at Baseline (Week 0) and Post-intervention (Week 14)
Nucleus Accumbens-Medial Prefrontal Cortex Functional Connectivity
MRI acquired at Baseline (Week 0) and Post-intervention (Week 14)
Whole-Brain Intrinsic Connectivity
MRI acquired at Baseline (Week 0) and Post-intervention (Week 14)
Fractional Anisotropy of NAc-mPFC White Matter Tract
MRI acquired at Baseline (Week 0) and Post-intervention (Week 14)
Peripheral Blood Gene Expression (RNA Sequencing)
Blood samples collected prior to Session 7 (first calibrated-intensity session, Week 3) and prior to Session 42 (final session, Week 14)
- +1 more secondary outcomes
Other Outcomes (2)
Submaximal Aerobic Power (subMAP85%)
Assessed at Baseline (Week 0) and Post-intervention (Week 14)
Six-Minute Walk Distance
Assessed at Baseline (Week 0) and Post-intervention (Week 14)
Study Arms (2)
Active intervention
EXPERIMENTALPhysical exercise training
Waitlist control
NO INTERVENTIONParticipants underwent all assessments but did not receive exercise training during the 14-week study period.
Interventions
60-minute sessions 3 times weekly Aerobic + resistance training Individually calibrated intensity (VO2max, 1RM) Total duration: 14 weeks
Eligibility Criteria
You may qualify if:
- Age ≥ 18 years
- Chronic low back pain ≥ 3 months
- Pain present at least half the days over the past 6 months
- Average pain intensity ≥ 3/10 during week prior to enrollment
You may not qualify if:
- Diabetes
- Neurological disorder
- Psychiatric disorder
- Significant cardiorespiratory disease
- Under 18 years of age
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- McGill Universitylead
- Canadian Institutes of Health Research (CIHR)collaborator
Study Sites (1)
Centre de Recherche de l'Institut Universitaire de Gériatrie de Montréal
Montreal, Quebec, H3W 1W4, Canada
Related Publications (7)
Hird EJ,Slanina-Davies A,Lewis G,Hamer M,Roiser JP
BACKGROUNDJiang R,Geha P,Rosenblatt M,Wang Y,Fu Z,Foster M,Dai W,Calhoun VD,Sui J,Spann MN,Scheinost D
BACKGROUNDGeneen LJ,Moore RA,Clarke C,Martin D,Colvin LA,Smith BH
BACKGROUNDParisien M,Lima LV,Dagostino C,El-Hachem N,Drury GL,Grant AV,Huising J,Verma V,Meloto CB,Silva JR,Dutra GGS,Markova T,Dang H,Tessier PA,Slade GD,Nackley AG,Ghasemlou N,Mogil JS,Allegri M,Diatchenko L
BACKGROUNDLesnak JB,Berardi G,Sluka KA
BACKGROUNDSchwartz N,Temkin P,Jurado S,Lim BK,Heifets BD,Polepalli JS,Malenka RC
BACKGROUNDBaliki MN, Petre B, Torbey S, Herrmann KM, Huang L, Schnitzer TJ, Fields HL, Apkarian AV. Corticostriatal functional connectivity predicts transition to chronic back pain. Nat Neurosci. 2012 Jul 1;15(8):1117-9. doi: 10.1038/nn.3153.
PMID: 22751038BACKGROUND
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
March 14, 2026
First Posted
March 18, 2026
Study Start
March 31, 2017
Primary Completion
December 14, 2021
Study Completion
December 14, 2021
Last Updated
March 18, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will not share